We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.09B
AUM Growth
-$471M
Cap. Flow
-$551M
Cap. Flow %
-26.44%
Top 10 Hldgs %
14.2%
Holding
1,734
New
546
Increased
219
Reduced
225
Closed
739

Top Sells

Rank Stock Value
1
FICO icon
Fair Isaac
FICO
+$50.2M
2
PODD icon
Insulet
PODD
+$47.5M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$46.2M
4
PRU icon
Prudential Financial
PRU
+$45.9M
5
CMI icon
Cummins
CMI
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 13.09%
2 Industrials 12.97%
3 Healthcare 12.43%
4 Consumer Discretionary 11.64%
5 Financials 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOOM icon
526
DMC Global
BOOM
$121M
$789K 0.04%
44,428
+33,732
+315% +$610K
PENN icon
527
PENN Entertainment
PENN
$2.74B
$784K 0.04%
+32,612
New +$869K
HALO icon
528
Halozyme
HALO
$9.72B
$781K 0.04%
21,664
-15,268
-41% -$521K
RLJ icon
529
RLJ Lodging Trust
RLJ
$1.87B
$777K 0.04%
75,657
-332,324
-81% -$3.45M
BIO icon
530
Bio-Rad Laboratories Class A
BIO
$8.42B
$773K 0.04%
2,039
-2,002
-50% -$815K
CALM icon
531
Cal-Maine
CALM
$4.28B
$771K 0.04%
17,124
-16,168
-49% -$803K
AZN icon
532
AstraZeneca
AZN
$263B
$765K 0.04%
5,348
-14,612
-73% -$2.15M
DLR icon
533
Digital Realty Trust
DLR
$73.7B
$762K 0.04%
6,691
-5,828
-47% -$577K
AMG icon
534
Affiliated Managers Group
AMG
$9.46B
$761K 0.04%
+5,079
New +$727K
FOLD
535
DELISTED
Amicus Therapeutics
FOLD
$760K 0.04%
60,549
-261,595
-81% -$3.1M
FWRD icon
536
Forward Air
FWRD
$482M
$760K 0.04%
7,158
+1,505
+27% +$154K
ARES icon
537
Ares Management
ARES
$28.5B
$756K 0.04%
+7,848
New +$678K
USPH icon
538
US Physical Therapy
USPH
$1.14B
$753K 0.04%
6,200
+2,492
+67% +$269K
FCX icon
539
Freeport-McMoran
FCX
$90B
$749K 0.04%
+18,726
New +$714K
AY
540
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$749K 0.04%
31,938
-46,628
-59% -$1.2M
THC icon
541
Tenet Healthcare
THC
$20.1B
$743K 0.04%
+9,132
New +$650K
BYD icon
542
Boyd Gaming
BYD
$6.47B
$740K 0.04%
+10,670
New +$717K
CVNA icon
543
Carvana
CVNA
$43.3B
$737K 0.04%
+142,240
New +$394K
ADI icon
544
Analog Devices
ADI
$181B
$736K 0.04%
3,780
-3,926
-51% -$727K
IDXX icon
545
Idexx Laboratories
IDXX
$42.9B
$736K 0.04%
1,465
+569
+64% +$273K
HWC icon
546
Hancock Whitney
HWC
$6.13B
$736K 0.04%
19,166
-6,106
-24% -$227K
GPC icon
547
Genuine Parts
GPC
$17.1B
$734K 0.04%
4,338
-185,073
-98% -$30.3M
WM icon
548
Waste Management
WM
$95.9B
$733K 0.04%
+4,224
New +$698K
FYBR
549
DELISTED
Frontier Communications
FYBR
$731K 0.04%
+39,235
New +$736K
UBSI icon
550
United Bankshares
UBSI
$6.55B
$730K 0.04%
24,608
-76,579
-76% -$2.41M

Similar funds

Ergoteles's Q2 2023 Portfolio in Review

As of Q2 2023, Ergoteles held 1,734 positions worth $2.09B, down 18% from $2.56B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Ergoteles withdrew a net $551M in Q2 2023, closing 739 positions and reducing 225 holdings. Its most notable exit was Insulet, an estimated $47.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Ergoteles opened a new position in State Street Communication Services Select Sector SPDR ETF worth $54.4M.

  • Ergoteles's largest Q2 2023 buy was State Street Communication Services Select Sector SPDR ETF: 835,265 shares worth $54.4M.
  • Ergoteles added most to State Street Industrial Select Sector SPDR ETF in Q2 2023, an estimated $26.2M increase.
  • Ergoteles's biggest Q2 2023 reduction was Fair Isaac, cutting an estimated $50.2M.
  • Ergoteles fully exited Insulet in Q2 2023, selling an estimated $47.5M.
  • Ergoteles's ten largest holdings make up 14% of its $2.09B portfolio in Q2 2023.
  • Ergoteles opened 546 new positions and closed 739 in Q2 2023.
  • Ergoteles's portfolio value fell 18% quarter-over-quarter to $2.09B.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.